Nuformix plc (LON:NFX – Get Free Report)’s share price traded up 16.4% during mid-day trading on Tuesday . The stock traded as high as GBX 0.23 ($0.00) and last traded at GBX 0.23 ($0.00). 74,319,828 shares changed hands during trading, an increase of 31% from the average session volume of 56,707,594 shares. The stock had previously closed at GBX 0.20 ($0.00).
Nuformix Price Performance
The business has a fifty day moving average of GBX 0.11 and a 200 day moving average of GBX 0.11. The stock has a market cap of £3.80 million, a price-to-earnings ratio of -56.00 and a beta of 1.22.
About Nuformix
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.
Featured Stories
- Five stocks we like better than Nuformix
- What is a Secondary Public Offering? What Investors Need to Know
- 3 REITs to Watch as Rate Cuts Ignite a Real Estate Super Cycle
- Should You Invest in Penny Stocks?
- 2 Defense Stocks Riding 2025’s Massive Momentum Wave
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- TrumpRx Brings Pfizer Into the Green—Is It a Buy?
Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.com's FREE daily email newsletter.
